Latest clinical trial News

Pandemic Science Hub to fight lung disease
Volunteers needed to trial scar-less wound healing cream
PT027, novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine
NeuroScientific Biopharmaceuticals submits for approval of early-phase trial
Volunteers receive first dose in clinical trial of Melbourne-made Covid vaccines
Texas Medical Center and Biodesign Australia announce partnership
Ultomiris met primary endpoint in CHAMPION-NMOSD Phase III trial
First subjects randomised and dosed in Paradigm’s late-stage trial
Adherium releases next generation respiratory platform integration services
Promising combination therapy for triple-negative breast cancer
NSW Government seeks operator for RNA manufacturing
WHO recommends highly successful Covid therapy and calls for wide geographical distribution and transparency from originator
Imugene says first cohort two patient dose in phase 1 clinical trial
New National PTSD Centre brings new hope to trauma survivors
$15 million to support Mitochondrial disease research
Australian research to support children with Mitochondrial disease
Accessible care key to treating hep C in people who inject drugs
New cancer drug formulations to be tested in Wollongong labs
NTCELL to be produced in Australia under UTS research agreement
Stroke recovery technology that re-launches Life
Positive impacts of Flash blood glucose monitoring on blood sugar and quality of life
Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
Leading Medical Research Reveals Real Patient Benefits from Pharmacist Prescribing
AstraZeneca aims to transform oncology treatment landscape with diverse early pipeline and novel combinations
Penile traction therapy
US FDA grants new orphan designation to Noxopharm’s Veyonda
Biotron updates on pre-clinical study of BIT225 in Covid
Game-changing new therapy to lower cholesterol and stabilise plaques associated with heart attack
Paradigm secures UK approvals for PARA_OA_002 clinical trial
Targeting viral lung infections two ways
Neuren receives ethics approval for Angelman Phase 2 trial
Update on US regulatory review of Fasenra in chronic rhinosinusitis with nasal polyps
Concerted action key to COVID vaccine development
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
GlyNAC supplementation extends life span in mice
ATAGI recommends Novavax for use as Covid booster
AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006
Exercise reduces clotting risk in patients with nonalcoholic fatty liver disease
Analogy-based education improves glycemic control in diabetic patients with hyperglycemia
Funding boost for ovarian cancer research
Grants support critical and otherwise unfunded ovarian cancer research
Patient possibly cured of HIV infection by special stem-cell transplant
Antibiotics affects gut microbes of newborns
Clinical trial investigates group naturopathic program for endometriosis
Amplia says new report ‘paves way’ for its phase 2 trial
Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants
Researchers one step closer to preventing asthma in children
WHO prequalifies first monoclonal antibody – tocilizumab – to treat Covid